Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Price Increases Reassure Cardinal

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer's recent round of price increases is in line with Cardinal's expectations, CEO Robert Walter said Jan. 12 at the J.P. Morgan health care conference in San Francisco

You may also be interested in...



Pfizer Says No To "Fee-For-Service" Contracts With Wholesalers

The manufacturer maintains that wholesalers "purchase and resell products for their own account and not as a service to Pfizer." Cardinal will no longer distribute Eisai products, including the Alzheimer's drug Aricept, marketed in partnership with Pfizer.

Pfizer Says No To "Fee-For-Service" Contracts With Wholesalers

The manufacturer maintains that wholesalers "purchase and resell products for their own account and not as a service to Pfizer." Cardinal will no longer distribute Eisai products, including the Alzheimer's drug Aricept, marketed in partnership with Pfizer.

Cardinal To Announce More Fee-For-Service Agreements Soon

Cardinal expects to announce more fee-for-service contracts with big manufacturers by mid-February, CEO Robert Walter said Jan. 12 at the J.P. Morgan health care conference in San Francisco

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel